-
2025-520678-20-00
5
Adult patients with symptomatic and inflammatory Hand osteoarthritis H
-
2024-517621-54-00
5
High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
-
2024-520140-42-00
5
Patients with primary HPV high-grade squamous intra-epithelial lesions
-
2025-524078-40-00
5
Chronic Spontaneous Urticaria
-
2024-513219-29-00
5
2024-10-21
Renal Cell Carcinoma
-
2023-503523-25-00
4
2024-02-29
Non-small cell lung cancer
-
2023-503920-14-00
5
2024-01-02
Non-Small Cell Lung Cancer (NSCLC)
-
2022-502959-54-00
5
2023-09-26
Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Ep
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2025-522395-92-00
5
2025-12-15
metastatic oeso-gastric adenocarcinoma
-
2025-520564-17-00
5
2025-10-16
Hidradenitis suppurativa (HS)
-
2024-514030-20-00
4
2025-08-29
colorectal cancer
-
2024-514560-10-00
4
2025-06-12
Patients with newly diagnosed advanced peritoneal metastasis from colo
-
2023-504554-35-00
5
2025-01-17
incisional hernia
-
2023-507860-37-00
9
2024-10-14
Breast cancer
-
2023-506753-38-00
4
2024-04-16
metastatic gastric adenocarcinoma
-
2023-503317-29-00
5
2024-04-12
Metastatic renal cell carcinoma (mRCC)
-
2022-502426-41-00
5
2023-10-17
Thromboprophylaxis in good and intermediate prognosis advanced germ ce
-
2023-503481-23-00
5
2023-03-20
Maintenance treatment in metastatic non-squamous lung cancer
-
2024-511896-13-00
11
2022-12-09
EA-COPD (with mechanical ventilation, invasive or non-invasive, or hig
-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2023-508072-11-00
5
2019-06-26
Castration-resistant prostate cancer
-
2024-517390-24-00
5
2011-04-26
Ovarian epithelial cancer : intraperitoneal resectable relapse
-
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)